Whereas most cannabis-related firms appear to be moving away from dried flower products, The Valens Company (TSX: VLNS) appears to be working in reverse. The company this morning announced that it has received an amendment to its sales license, enabling the sale of certain dried flower products.
In a time where most producers are moving away from dried flower and related “cannabis 1.0” products, Valens appears to be going full steam ahead. The company this morning indicated that it had sought the amendment to enable the firm to sell pre-rolls and dried cannabis derivative products.
New products in numerous blends and sizes are reportedly in development at the firms K2 facility in British Columbia. The new products are reportedly the result of partners requesting the additional formats, with the firm now able to offer a wide range of product offers.
The Valens Company last traded at $1.97 on the TSX.
Information for this briefing was found via Sedar and The Valens Company. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.